Atlas Trials

Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy

Clinical trial NCT04090736 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04090736
Sponsor
PETHEMA Foundation
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Leukemia, Myeloid, Acute
Start date
2019-09-24
Primary completion
2023-06-30
Enrollment
302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.